• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail

Refusal Actions by FDA as Recorded in OASIS

for 61-Human and Animal Drugs

Entry/doc/line/sfx Refusal Date Product
112-2172237-7/1/3 14-May-2008 61EBA99 3001229217 Zuellig Pharma Corporation Philippines
M21-0737706-3/1/1 27-May-2008 61FAE53 3004850451 Wendt-Chemie Vertriebsges Mbh & Co. Germany
946-0607162-2/147/1 12-May-2008 61FAL21 3003740869 Reckitt Benkiser Ltd United Kingdom
UPS-0651331-9/1/1 14-May-2008 61GCY70 3004125535 Laboratorios LAFI Ltda. Chile
112-0424587-5/2/1 28-May-2008 61HAL17 3004795214 Proctor & Gamble United States
T94-0047699-8/1/1 06-May-2008 61HCS03 3003941038 Shouguang Fukang Pharmaceutical Co., Ltd. China
112-2389939-7/1/4 21-May-2008 61JCA14 3003933424 Pharex Philippines
231-5220291-0/1/1 12-May-2008 61JIA99 3003431146 MSD International GmbH (Singapore Branch) Singapore
224-0360913-8/1/8 23-May-2008 61KCP05 2016148 International Medication Systems Limited United States
336-7496059-9/3/1 20-May-2008 61KCS99 3002806556 Boehringer Ingelheim Pharma GmbH & Co. KG Germany
224-0360913-8/1/9 23-May-2008 61LCP20 3005339463 Hospira, Inc. United States
112-2389939-7/2/1 21-May-2008 61PCA31 3004442551 Therapharma Philippines
KH5-0032984-3/1/1 29-May-2008 61SDQ99 3005726903 Aerosol Scandinavia Ab Sweden
KH5-0033130-2/1/1 29-May-2008 61SDQ99 3005726903 Aerosol Scandinavia Ab Sweden
XXX-0154083-1/1/17 28-May-2008 61TAC02 3004581869 La boratorios Unido S.A. Guatemala
AEK-9475366-8/1/1 14-May-2008 61TCY99 3003941498 Wiler Pcca Ltd Canada
XXX-0154083-1/1/18 28-May-2008 61WAF45 3005035920 Caplin Point Laboratories Ltd India
XXX-0154083-1/1/4 28-May-2008 61XCP08 3004069870 Laboratorios PIERSAN Guatemala
224-0360913-8/1/6 23-May-2008 61XCP18 1420763 Medique Products United States
224-0360913-8/1/1 23-May-2008 61XPC18 3002138941 Baxter Health Care United States